Cargando…

A Combination of Low Doses of Fluvastatin and Valsartan Decreases Arterial Stiffness in Patients After Myocardial Infarction: A Pilot Study

BACKGROUND: Despite optimum treatment, patients who experience myocardial infarction are still at high risk for future events. OBJECTIVE: We evaluated the effect of 30 days of treatment with combination of low, subtherapeutic doses of fluvastatin and valsartan on arterial stiffness in patients after...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hanžel, Jurij, Piletič, Žiga, Turk, Martina, Eržen, Barbara, Šabovič, Mišo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2015
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4506977/ https://www.ncbi.nlm.nih.gov/pubmed/26199676 http://dx.doi.org/10.1016/j.curtheres.2015.06.001

Ejemplares similares

Improving Arterial Wall Characteristics in Patients After Myocardial Infarction with a Very Low Dose of Fluvastatin and Valsartan: A Proof-of-Concept Study
por: Veselič, Martina Turk, et al.
Publicado: (2018)

A Low-Dose Combination of Fluvastatin and Valsartan: A New “Drug” and a New Approach for Decreasing the Arterial Age
por: Janić, Miodrag, et al.
Publicado: (2015)

Expression of Longevity Genes Induced by a Low-Dose Fluvastatin and Valsartan Combination with the Potential to Prevent/Treat “Aging-Related Disorders”
por: Janić, Miodrag, et al.
Publicado: (2019)

Arterial Stiffness and Cardiovascular Therapy
por: Janić, Miodrag, et al.
Publicado: (2014)

Coenzyme Q10 Supplementation Decreases Statin-Related Mild-to-Moderate Muscle Symptoms: A Randomized Clinical Study
por: Skarlovnik, Ajda, et al.
Publicado: (2014)

Stable phase post-MI patients have elevated VEGF levels correlated with inflammation markers, but not with atherosclerotic burden
por: Eržen, Barbara, et al.
Publicado: (2014)

Fluvastatin inhibits cardiomyocyte apoptosis after myocardial infarction through Toll pathway
por: Jia, Lili, et al.
Publicado: (2018)

Fluvastatin inhibits cardiomyocyte apoptosis after myocardial infarction through Toll pathway
por: Jia, Lili, et al.
Publicado: (2018)

Fluvastatin protects myocardial cells in mice with acute myocardial infarction through inhibiting RhoA/ROCK pathway
por: Yi, Zhenci, et al.
Publicado: (2020)

Combined treatment with valsartan and fluvastatin to delay disease progression in nonpermanent atrial fibrillation with hypertension: A clinical trial
por: Zhao, Zhiqiang, et al.
Publicado: (2020)

Efficacy and safety of sacubitril/valsartan vs. valsartan in patients with acute myocardial infarction: A meta-analysis
por: Yang, Pei, et al.
Publicado: (2022)

Enantiospecific Pharmacogenomics of Fluvastatin
por: Hirvensalo, Päivi, et al.
Publicado: (2019)

The impact of a dose of the angiotensin receptor blocker valsartan on post‐myocardial infarction ventricular remodelling
por: Park, Kyungil, et al.
Publicado: (2018)

Valsartan in the treatment of heart failure or left ventricular dysfunction after myocardial infarction
por: Bissessor, Naylin, et al.
Publicado: (2007)

Does sacubitril/valsartan work in acute myocardial infarction? The PARADISE-AMI study
por: Gatto, Laura
Publicado: (2021)

The Difference in Pharmacokinetics and Pharmacodynamics between Extended-Release Fluvastatin and Immediate-Release Fluvastatin in Healthy Chinese Subjects
por: Xu, H. R., et al.
Publicado: (2012)

A pilot window-of-opportunity study of preoperative fluvastatin in localized prostate cancer
por: Longo, Joseph, et al.
Publicado: (2020)

The effect of cardioprotective diet rich with natural antioxidants on chronic inflammation and oxidized LDL during cardiac rehabilitation in patients after acute myocardial infarction
por: Mlakar, Polona, et al.
Publicado: (2015)

Effects of Fluvastatin on Characteristics of Stellate Ganglion Neurons in a Rabbit Model of Myocardial Ischemia
por: Cheng, Li-Jun, et al.
Publicado: (2016)

Modulation of Ion Channels in the Superior Cervical Ganglion Neurons by Myocardial Ischemia and Fluvastatin Treatment
por: Cheng, Lijun, et al.
Publicado: (2018)

Effects of Fluvastatin on the Pharmacokinetics of Repaglinide: Possible Role of CYP3A4 and P-glycoprotein Inhibition by Fluvastatin
por: Lee, Chong-Ki, et al.
Publicado: (2013)

Effects of valsartan on ventricular arrhythmia induced by programmed electrical stimulation in rats with myocardial infarction
por: Jiao, Kun-Li, et al.
Publicado: (2012)

Cardioprotective Effects of LCZ696 (Sacubitril/Valsartan) After Experimental Acute Myocardial Infarction
por: Ishii, Masanobu, et al.
Publicado: (2017)

Sacubitril/valsartan averts post-myocardial infarction ventricular remodeling and preserves heart function
por: Hajra, Adrija, et al.
Publicado: (2019)

Protective effect of sacubitril/valsartan in patients with acute myocardial infarction: A meta-analysis
por: Liu, Shanshan, et al.
Publicado: (2022)

Upstream therapeutic strategies of Valsartan and Fluvastatin on Hypertensive patients with non-permanent Atrial Fibrillation (VF-HT-AF): study protocol for a randomized controlled trial
por: Qi, Wen-Wei, et al.
Publicado: (2015)

Fluvastatin therapy could not decrease progression of paroxysmal atrial fibrillation in non-valvular disease patients
por: Tan, Qiang, et al.
Publicado: (2017)

Sacubitril/Valsartan Improves Cardiac Function and Decreases Myocardial Fibrosis Via Downregulation of Exosomal miR‐181a in a Rodent Chronic Myocardial Infarction Model
por: Vaskova, Evgeniya, et al.
Publicado: (2020)

The presence of cerebral and/or systemic endothelial dysfunction in patients with leukoaraiosis - a case control pilot study
por: Zupan, Matija, et al.
Publicado: (2015)

Effect of sacubitril/valsartan or valsartan on ventricular remodeling and myocardial fibrosis in perimenopausal women with hypertension
por: Chen, Jianshu, et al.
Publicado: (2023)

Effects and Safety of Sacubitril/Valsartan for Patients with Myocardial Infarction: A Systematic Review and Meta-Analysis
por: Liu, Lang, et al.
Publicado: (2022)

The benefits of sacubitril–valsartan in patients with acute myocardial infarction: a systematic review and meta‐analysis
por: Xiong, Bo, et al.
Publicado: (2021)

Effects of sacubitril/valsartan on cardiac reverse remodeling and cardiac resynchronization in patients with acute myocardial infarction
por: Yang, Pei, et al.
Publicado: (2023)

Lipoprotein(a) and inflammation in patients with atrial fibrillation after electrical cardioversion
por: Naji, Franjo, et al.
Publicado: (2011)

Inflammatory, Metabolic, and Coagulation Effects on Medial Arterial Calcification in Patients with Peripheral Arterial Disease
por: Nikolajević, Jovana, et al.
Publicado: (2023)

Refractory drug-induced systemic small-vessel vasculitis with two varied extracutaneous manifestations: a case report and review of the literature
por: Jovanovic, Mark, et al.
Publicado: (2023)

Kinetic Spectrophotometric Determination of Fluvastatin in Pharmaceutical Preparations
por: Ashour, Safwan, et al.
Publicado: (2010)

Influence of Aerobic Training on The Mechanics of Ventricular Contraction After Acute Myocardial Infarction: A Pilot Study
por: Santi, Giovani Luiz De, et al.
Publicado: (2018)

Gastric ectopic pancreas mimicking a gastrointestinal stromal tumour: A case report
por: Štor, Zdravko, et al.
Publicado: (2018)

Ileal leiomyosarcoma presenting with intussusception
por: Štor, Zdravko, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_5ilqfocklb97fd8a22j0m1j4qm